Summary
A CANCER charity yesterday hailed the approval of a new prostate cancer drug used to treat patients in the advanced stages of the disease.
Abiraterone acetate, which has the brand name Zytiga, was approved by the European Commission in the last few days.See the full content of this document
Extract
Cancer Charity Hails New Drug
It is being considered for use in England a...
See the full content of this document
Sponsored links
